Adverse Drug Reactions
Medivation Announces Publication In the Lancet of Dimebon Pivotal Trial Results In Alzheimers Disease
Published in Mental Health Business Week, August 9th, 2008
Medivation, Inc. (NASDAQ: MDVN) announced publication of the results of its first Alzheimer's disease pivotal clinical trial of the investigational drug Dimebon in the July 19, 2008 issue of The Lancet. In this double-blind, placebo-controlled trial, patients with mild-to-moderate Alzheimer's disease treated with Dimebon experienced statistically significant improvements compared to placebo in all the key aspects of the disease: memory and thinking, activities of daily living, behavior and overall function.
After both six months and a full year of treatment, Dimebon-treated patients were significantly better than placebo-treated patients on all key aspects of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- AFS Trinity
Reaction to AFS Trinity's 150 mpg Extreme Hybrid Indicates Reported Death of SUVs 'Greatly Exaggerated' - Alexza Pharmaceuticals, Inc.
Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 Staccato Loxapine - Amerigroup Holdings, Inc.
MDwebLive Expands Services by Establishing Mental Healthcare Program - Anxiety Disorders
CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study - Autism
Buchanan Street Partners Issues a Matching Funds Donation Challenge to Support Families Affected By Autism - Autism
International Rugby Match To Benefit Autism Research - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
